In this article published in The Pink Sheet, Tim Wilsdon and Ryan Lawlor explore the relationship between various procurement models and vaccine coverage rates in Europe. They discuss how certain procurement methods help contribute to a sustainable “vaccine ecosystem.”
To read the article, click here.
Note: subscription required to access
Strategic implications for the 340B Rebate Model Pilot Program
These entities receive discounts on all eligible covered outpatient drugs. The program has expanded substantially over the years, with the number of covered...
